Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
60
Expiration
Mar 19, 2027
DTE
163d
Moneyness
OTM
Intrinsic
$0.00
EWTX 60 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $0.18 | -43.75% | 3 | 21 |
| Nov 20, 2026 | 44d | $1.75 | -17.84% | 3 | 90 |
| Dec 18, 2026 | 72d | $1.10 | -60.71% | 3 | 8 |
| Jan 15, 2027 | 100d | $1.25 | -58.33% | 1 | 9 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | $2.30 | +2.22% | 1 | 32 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.